InvestorsHub Logo
Followers 11
Posts 214
Boards Moderated 0
Alias Born 03/21/2018

Re: stervc post# 16705

Sunday, 11/22/2020 5:43:47 PM

Sunday, November 22, 2020 5:43:47 PM

Post# of 23619
Agree with you. The contact info is very interesting. Seems to me Vibi and Canta have a winner.. Vibi with the nanotech to deliver Cantabios dj-1 protein to inhibit a-synuclein aggregation to stop early onset of Parkinson disease. As far as Cantabio being shady or a scam.. Definitely not. They worked with Purdue University and published novel studies demonstrating importance of dj-1 protein in the onset and pathology of Alzheimers and Parkinsons. Obviously the results of the studies were very successful hence the grant.. They did receive grant from Michael J Fox foundation. I thought that was years ago but actually just got grant few months ago. Here is a link from Purdue https://www.purdue.edu/newsroom/releases/2016/Q3/cantabio,-purdue-sign-agreement-to-investigate-targeting-of-dj-1-protein-for-treating-parkinsons-diseases.html And here is a link with a telling pdf https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.racap.com/media/TechAtlas/RACapital_Parkinsons_Disease_V2.pdf&ved=2ahUKEwiyqMbulZftAhUaTDABHXynDDUQFjADegQICBAB&usg=AOvVaw35GrMBnqB6CO-jDes6bEfc If you look on the right side about half way down you see Cantabios role in this (CB 101,102,201) from RA Capital. Great find S!! $VIBI$

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.